Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Global Coconut Group is a leading manufacturer of coconut-derived ingredients with specialized applications in the pharmaceutical, nutraceutical, and clinical nutrition industries. The company is a major producer of Medium Chain Triglycerides (MCTs), which are utilized as high-energy nutritional supplements for patients with malabsorption disorders and as lipid-based excipients in drug delivery systems. Additionally, the group manufactures high-purity activated carbon from coconut shells, a critical material for pharmaceutical purification, decolorization, and the treatment of acute poisonings. Headquartered in Pollachi, India, Global Coconut Group operates state-of-the-art facilities that comply with international quality standards such as GMP and ISO. The company serves a global market, providing natural and sustainable ingredients for a wide range of healthcare and wellness products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Global Coconut.